Global Stelara Market Analysis: Size, Trends, Growth, and Competitive Landscape The Stelara market is undergoing a significant transformation characterized by declining demand due to emerging alternatives and evolving treatment protocols. As key players adapt to these shifts, understanding the market size and revenue dynamics remains crucial for stakeholders exploring future opportunities and challenges within this specialized therapeutic segment. Market Size and Overview The Global Stelara Market is estimated to be valued at USD 9,532.3 Million in 2026 and is expected to reach USD 2,963.1 Million by 2033, exhibiting a compound annual growth rate (CAGR) of -15.2% from 2026 to 2033. Market Segments The Stelara market is segmented primarily by indication, dosage form, and distribution channel. - Indication: The dominant sub-segment is psoriasis, maintaining the largest market size due to established clinical usage. However, the fastest-growing sub-segment is Crohn’s disease, accelerated by expanding label approvals in 2025 and increasing patient adoption. - Dosage Form: Injectable formulations dominate the Stelara market share, accounting for nearly 90% of market revenue in 2026, driven by enhanced delivery innovations improving patient adherence. - Distribution Channel: Hospital pharmacies lead in Stelara Market Revenue due to high volumes of administration, whereas specialty clinics represent the fastest-growing sub-segment with adoption rates increasing by 12% year-over-year as observed in 2025. Stelara Market: https://www.coherentmarketinsights.com/industry-reports/stelara-market